(Q36752176)

English

Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection

scientific article published on September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

0 references

author name string

Marie Matignon

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Thangamani Muthukumar

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Surya V Seshan

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Manikkam Suthanthiran

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Choli Hartono

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

1 September 2012

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Transplantation

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

94

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

603-611

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

29 September 2017

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

29 September 2017

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

29 September 2017

A new equation to estimate glomerular filtration rate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

29 September 2017

Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

29 September 2017

Summary of FDA antibody-mediated rejection workshop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

28 June 2018

Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

28 June 2018

A personal perspective: 100-year history of the humoral theory of transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

5 September 2018

Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

5 September 2018

Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

5 September 2018

Beyond histology: lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

5 September 2018

Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

5 September 2018

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

5 September 2018

Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

5 September 2018

Effect of histological damage on long-term kidney transplant outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3621127

5 September 2018

Role of humoral presenitization in human renal transplant rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capillary deposition of C4d complement fragment and early renal graft loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of donor source, recipient age, pre-operative immunotherapy and induction therapy on early and late acute rejections in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of poor graft outcome in patients with antibody-mediated acute rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rituximab therapy for acute humoral rejection after kidney transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early versus late acute rejection episodes in renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22932115

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/TP.0B013E31825DEF05

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36752176&oldid=2078532931"